Cargando…
Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study
INTRODUCTION: The acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has a seriously negative impact on patients’ healths condition and disease progression. Bacterial infection is closely related to AECOPD, and antibiotics are frequently used in clinical practice. The lack of speci...
Autores principales: | Yang, Mei, Liu, Xuemei, Hu, Qiongqiong, Li, Junjie, Fu, Sijia, Chen, Daohong, Wu, Yanqing, Luo, Ai, Zhang, Xiawei, Feng, Ruizhi, Xu, Guo, Liu, Can, Jiang, Hongli, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783821/ https://www.ncbi.nlm.nih.gov/pubmed/35058259 http://dx.doi.org/10.1136/bmjopen-2021-051939 |
Ejemplares similares
-
Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol
por: Luo, Ai, et al.
Publicado: (2022) -
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023) -
The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study
por: Schmidt, Sigrun Alba Johannesdottir, et al.
Publicado: (2014) -
Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013) -
Mortality and readmission risk for hospitalised patients with acute exacerbation of COPD with and without spirometric obstruction: a longitudinal observational study in China
por: Ren, Xiaoxia, et al.
Publicado: (2023)